193 related articles for article (PubMed ID: 29804202)
1. Salvage topical therapy for upper tract urothelial carcinoma.
Balasubramanian A; Metcalfe MJ; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
World J Urol; 2018 Dec; 36(12):2027-2034. PubMed ID: 29804202
[TBL] [Abstract][Full Text] [Related]
2. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
Audenet F; Traxer O; Bensalah K; Rouprêt M
World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
[TBL] [Abstract][Full Text] [Related]
3. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
[TBL] [Abstract][Full Text] [Related]
4. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
Thalmann GN; Markwalder R; Walter B; Studer UE
J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
[TBL] [Abstract][Full Text] [Related]
6. Novel treatment of upper tract urothelial carcinoma in situ with docetaxel in BCG refractory patients.
Katims AB; Tam AW; Rosen DC; Zampini AM; Atallah W; Mehrazin R; Gupta M
Urol Oncol; 2021 Apr; 39(4):234.e9-234.e13. PubMed ID: 32958446
[TBL] [Abstract][Full Text] [Related]
7. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.
Mandalapu RS; Remzi M; de Reijke TM; Margulis V; Palou J; Kapoor A; Yossepowitch O; Coleman J; Traxer O; Anderson JK; Catto J; de la Rosette J; O'Brien T; Zlotta A; Matin SF
World J Urol; 2017 Mar; 35(3):355-365. PubMed ID: 27233780
[TBL] [Abstract][Full Text] [Related]
8. Nephron-sparing management of upper tract urothelial carcinoma.
Farrow JM; Kern SQ; Gryzinski GM; Sundaram CP
Investig Clin Urol; 2021 Jul; 62(4):389-398. PubMed ID: 34190434
[TBL] [Abstract][Full Text] [Related]
9. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
[TBL] [Abstract][Full Text] [Related]
10. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
Eastham JA; Huffman JL
J Urol; 1993 Aug; 150(2 Pt 1):324-5. PubMed ID: 8326553
[TBL] [Abstract][Full Text] [Related]
11. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
[TBL] [Abstract][Full Text] [Related]
12. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ.
McElree IM; Mott SL; Hougen HY; Packiam VT; O'Donnell MA; Steinberg RL
Urol Oncol; 2024 Jul; 42(7):221.e9-221.e16. PubMed ID: 38609747
[TBL] [Abstract][Full Text] [Related]
13. A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma.
Kesch C; Schmitt V; Bidnur S; Thi M; Beraldi E; Moskalev I; Yago V; Bowden M; Adomat H; Fazli L; Jackson JK; Gleave ME
Urol Oncol; 2021 Mar; 39(3):194.e1-194.e7. PubMed ID: 33250343
[TBL] [Abstract][Full Text] [Related]
14. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
15. Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
Territo A; Fontanet S; Meneghetti I; Gallioli A; Sanguedolce F; Rodriguez-Faba Ó; Gaya JM; Palou J; Huguet J; Breda A
Actas Urol Esp (Engl Ed); 2023 May; 47(4):221-228. PubMed ID: 36379260
[TBL] [Abstract][Full Text] [Related]
16. Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma.
McElree IM; Belzer A; Mott SL; Packiam VT; O'Donnell MA; Steinberg RL
Urol Oncol; 2024 Jan; 42(1):20.e9-20.e15. PubMed ID: 37805338
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant topical treatment of upper urinary tract urothelial tumours.
O'Donoghue JP; Crew JP
BJU Int; 2004 Sep; 94(4):483-5. PubMed ID: 15329096
[No Abstract] [Full Text] [Related]
19. Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature.
Foerster B; D'Andrea D; Abufaraj M; Broenimann S; Karakiewicz PI; Rouprêt M; Gontero P; Lerner SP; Shariat SF; Soria F
Urol Oncol; 2019 Jul; 37(7):430-436. PubMed ID: 30846387
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]